Ophthotech Corp (OPHT) Misses Q3 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Ophthotech Reports Third Quarter 2015 Financial and Operating Results
November 5, 2015 7:15 AM EST- Conference Call and Webcast Today, November 5, 2015, at 8:00 a.m. ET -
NEW YORK--(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq: OPHT) today announced financial results for the third quarter ended September 30, 2015 and provided an update on the Companys business and product development programs.
We have achieved many significant milestones that have us on track to reach our goal to provide initial, topline data from both Phase 3 trials of Fovista® in combination with Lucentis in the fourth quarter of 2016, said David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board of Ophthotech.
... More
